Deciphering the MHC-associated peptidome: a review of naturally processed ligand data
暂无分享,去创建一个
[1] Bjoern Peters,et al. The Immune Epitope Database: How Data Are Entered and Retrieved , 2017, Journal of immunology research.
[2] Bjoern Peters,et al. The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design , 2017, Front. Immunol..
[3] S. Lemieux,et al. MHC class I-associated peptides derive from selective regions of the human genome. , 2016, The Journal of clinical investigation.
[4] M. Mann,et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry , 2016, Nature Communications.
[5] Etienne Caron,et al. Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry* , 2015, Molecular & Cellular Proteomics.
[6] Deborah Hix,et al. The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..
[7] Ruedi Aebersold,et al. Analysis of MHC immunopeptidomes using mass , 2015 .
[8] Philip R. Johnson,et al. Accelerating Next-Generation Vaccine Development for Global Disease Prevention , 2013, Science.
[9] J. Leunissen,et al. The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes* , 2013, Molecular & Cellular Proteomics.
[10] Ilan Beer,et al. Soluble plasma HLA peptidome as a potential source for cancer biomarkers , 2010, Proceedings of the National Academy of Sciences.
[11] P. Lackner,et al. Naturally processed T cell-activating peptides of the major birch pollen allergen. , 2010, The Journal of allergy and clinical immunology.
[12] Bjoern Peters,et al. Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance1 , 2008, The Journal of Immunology.
[13] A. Louise,et al. Assessment of Bet v 1-Specific CD4+ T Cell Responses in Allergic and Nonallergic Individuals Using MHC Class II Peptide Tetramers1 , 2008, The Journal of Immunology.
[14] James McCluskey,et al. More than one reason to rethink the use of peptides in vaccine design , 2007, Nature Reviews Drug Discovery.
[15] J. Yewdell,et al. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. , 2006, Immunity.
[16] Eric W. Deutsch,et al. The PeptideAtlas project , 2005, Nucleic Acids Res..
[17] Steve Wilson,et al. The Immune Epitope Database and Analysis Resource: From Vision to Blueprint , 2005, PLoS biology.
[18] Sorin Istrail,et al. Comparative immunopeptidomics of humans and their pathogens. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Aebersold,et al. Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS. , 2004, Drug discovery today.
[20] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[21] M. Lotze,et al. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[22] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[23] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[24] Hans-Georg Rammensee,et al. Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.
[25] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[26] H. Rammensee,et al. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. , 1990, Science.